MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers
Wenrui Duan(Dalian Medical University), Miguel A. Villalona‐Calero(University of California, Irvine)
Cited by 5
Related Papers
Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
|Journal of Clinical Oncology|2011|304
MicroRNA‐34a is an important component of PRIMA‐1‐induced apoptotic network in human lung cancer cells
|International Journal of Cancer|2009|27